Medicare revenue for urologists will drop 14% in 2005

Washington--The Centers for Medicare & Medicaid Services has published its final rule implementing the 2005 Medicare fee schedule, and it's not good news for urologists-especially those who administer cancer drugs in their offices.

Related Content:

Drug TherapyPractice Management

Urology Times Money Matters: Alternative Investments

What can be learned from CMS data on health care spending?

FDA finalizes blueprint for cancer drug trials involving patients with CNS metastases